Standout Papers

Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients wit... 2018 2026 2020 2023 264
  1. Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia (2018)
    Piers Blombery, Mary Ann Anderson et al. Cancer Discovery

Citation Impact

7 by Nobel laureates 12 from Science/Nature 56 standout
Sub-graph 1 of 22

Citing Papers

MetaboAnalyst 6.0: towards a unified platform for metabolomics data processing, analysis and interpretation
2024 Standout
Cell death
2024 Standout
6 intermediate papers

Works of Charis E. Teh being referenced

Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia
2018 Standout
The combination of reduced MCL-1 and standard chemotherapeutics is tolerable in mice
2017
and 2 more

Author Peers

Author Immunology Molecular Biology Genetics Last Decade Papers Cites
Charis E. Teh 399 419 226 33 920
R. Korenstein 21 333
Chi Zhang 1 20 360
Émilie Berteaud 1 22 105 7 297
Robin Wardle 8 421
C. Richard Spates 5 27 785

All Works

Loading papers...

Rankless by CCL
2026